Dover has entered into a definitive settlement to amass Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s merchandise will expand Dover’s biopharma single-use manufacturing providing, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in pressure gauge , Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue through the full year 2022.
When the deal closes, Malema will become part of the PSG business unit within Dover’s Pumps & Process Solutions phase.
“We see a tremendous long-term development opportunity within the bioprocessing business pushed by a strong and growing pipeline of effective novel biologic medication, biosimilars, protein therapies, non-COVID mRNA vaccines, as well as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, เกจวัดแรงดัน growing adoption of extra environment friendly single-use manufacturing processes helps a sturdy outlook for our offerings of single-use components to end-customers. We believe that pairing Malema’s expertise with our present portfolio of single-use pumps for biopharma processing will tremendously improve the accuracy and worth proposition of our options to our clients.”
“We are methodically building out our biopharma platform via proactive capability additions, new product development, and opportunistic acquisitions of highly-attractive niche part applied sciences,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and further strengthens our sensor portfolio with new proprietary expertise. In addition to engaging biopharma purposes, we anticipate sturdy growth in the semiconductor space on the capacity growth and re-shoring tailwinds.”
Share